Valuation (52%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 33.89 | N/A |
| PEG Ratio (TTM) | 27.17 | N/A |
| P/S Ratio (TTM) | 12.74 | N/A |
| P/B Ratio (TTM) | 2.78 | N/A |
| P/FCF Ratio (TTM) | 22.38 | N/A |
| Price to 5YR AVG Earnings Ratio | 50.16 | N/A |
| Price to 5YR AVG FCF Ratio | 34.47 | N/A |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.89% | N/A |
| ROE (TTM) | 8.56% | N/A |
| Net Profit Margin (TTM) | 37.11% | N/A |
| ROIC 5YR AVG | 5.02% | N/A |
Growth (80%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 2.33% | 12.38% | 16.17% |
| Revenue | 2.68% | 10.89% | 13.75% |
| Net Income | 4.07% | 17.07% | 21.86% |
| Cash Flow | 35.84% | 16.60% | 16.01% |
Health (51%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.57 | N/A |
| Quick Ratio (TTM) | 0.57 | N/A |
| D/E Ratio (TTM) | 0.57 | N/A |
| Interest Coverage (TTM) | 27.26 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 2.66 | N/A |
| LTL to 5YR AVG FCF | 6.58 | N/A |
| Shares Outstanding Growth 5YR AVG | 5.01% | N/A |